Equities

Invion Ltd

Invion Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.005
  • Today's Change0.00 / 0.00%
  • Shares traded134.04k
  • 1 Year change-28.57%
  • Beta1.0296
Data delayed at least 20 minutes, as of Apr 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • IVX:ASX price moved over -9.09% to 0.005
  • IVX:ASX price rises above 200-day moving average to 0.006 at 11:04 BST
  • IVX:ASX price falls below 15-day moving average to 0.005 at 17:10 BST

Key statistics

On Tuesday, Invion Ltd (IVX:ASX) closed at 0.005, 25.00% above the 52 week low of 0.004 set on Mar 04, 2024.
52-week range
Today
0.004Mar 04 20240.008Nov 22 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.005
High0.005
Low0.005
Bid0.006
Offer0.005
Previous close0.005
Average volume786.98k
Shares outstanding6.42bn
Free float3.27bn
P/E (TTM)--
Market cap32.12m AUD
EPS (TTM)-0.0002
AUD
Data delayed at least 20 minutes, as of Apr 16 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.